Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain HSKA message board posts where the ticker symbol HSKA has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest HSKA SEC Filings

Filings Format Description Filing Date File/Film Number
8-K  Documents Current report, items 5.02 and 9.01
Acc-no: 0001038133-17-000061 (34 Act)  Size: 82 KB
2017-12-07 000-22427
171245528
8-K  Documents Current report, items 5.02 and 9.01
Acc-no: 0001038133-17-000059 (34 Act)  Size: 36 KB
2017-12-06 000-22427
171240788
3  Documents Initial statement of beneficial ownership of securities
Acc-no: 0001237648-17-000073 Size: 5 KB
2017-12-04
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001237648-17-000071 Size: 4 KB
2017-12-04
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001237648-17-000068 Size: 6 KB
2017-11-29
10-Q  Documents   Interactive Data Quarterly report [Sections 13 or 15(d)]
Acc-no: 0001038133-17-000054 (34 Act)  Size: 5 MB
2017-11-03 000-22427
171175342
8-K  Documents Current report, items 2.02 and 9.01
Acc-no: 0001038133-17-000051 (34 Act)  Size: 267 KB
2017-11-02 000-22427
171171062
CT ORDER  Documents Confidential treatment order
Acc-no: 9999999997-17-008487 (34 Act)  Size: 13 KB
2017-09-05 000-22427
171067798
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001237648-17-000066 Size: 4 KB
2017-08-31
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001237648-17-000064 Size: 42 KB
2017-08-31
More HSKA SEC Filings


Related news from
Fri, 01 Dec 2017
21:05:00 +0000
Heska promotes Catherine Grassman to Vice President and Chief Accounting Officer and announces executive departure
"Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, announced today that Catherine Grassman is promoted to Vice President, Chief Accounting Officer and Controller following the departure of John McMahon, Vice President and Chief Financial Officer. "Catherine is a deeply experienced financial executive who already knows Heska well and is highly qualified to serve as vice president and principal accounting officer," commented Kevin Wilson, President and Chief Executive Officer. "Catherine has been a central figure in the Company's accounting and finance leadership throughout 2017.
Mon, 27 Nov 2017
19:09:37 +0000
ETFs with exposure to Heska Corp. : November 27, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Heska Corp. Here are 5 ETFs with the largest exposure to HSKA-US. Comparing the performance and risk of Heska Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more <b>(Read more...)</b>
Tue, 21 Nov 2017
17:33:01 +0000
Mariko Gordon Starts 5 New Positions in 3rd Quarter
Daruma leader exits four other holdings
Mon, 06 Nov 2017
23:16:46 +0000
Edited Transcript of HSKA earnings conference call or presentation 2-Nov-17 3:00pm GMT
Q3 2017 Heska Corp Earnings Call
Mon, 06 Nov 2017
18:07:09 +0000
Heska Corp. – Value Analysis (NASDAQ:HSKA) : November 6, 2017
Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Heska Corp. a score of 69. Our analysis is based on comparing Heska Corp. with the following peers – ImmuCell Corporation, IDEXX Laboratories, Inc., Merck & Co., Inc., Abaxis, Inc., Pfizer Inc., Eli Lilly and Company, Zoetis, Inc. Class A and Novartis AG Sponsored ADR (ICCC-US, IDXX-US, ... Read more <b>(Read more...)</b>
Fri, 03 Nov 2017
12:34:59 +0000
Heska Corp. breached its 50 day moving average in a Bearish Manner : HSKA-US : November 3, 2017
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Heska Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bearish 50 ... Read more <b>(Read more...)</b>
Thu, 02 Nov 2017
12:25:56 +0000
Heska beats 3Q profit forecasts
The Loveland, Colorado-based company said it had profit of 40 cents per share. The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research ...
Thu, 02 Nov 2017
12:00:00 +0000
Heska Reports Third Quarter Results
- 16% growth in year over year core blood diagnostics instruments and consumables revenue - Gross margins up 210bps year over year to 43.1% - Records $3.8 million of operating income in the quarter, bringing ...
Wed, 01 Nov 2017
12:00:00 +0000
Heska Announces 7-Year Agreement with PetVetCare Centers
"Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, announced today an agreement to supply over 100 PetVetCare Centers ("PetVetCare") veterinary hospitals with in-house laboratory diagnostic equipment and supplies through 2024, which may be extended by the Parties. Under the agreement, Heska's in-house blood diagnostics analyzers will be placed into PetVetCare's general, specialty referral, and emergency hospitals throughout the United States. PetVetCare is one of the nation's top five veterinary healthcare providers and currently represents roughly 0.5% of full-service veterinary hospitals in the United States.
Tue, 31 Oct 2017
12:00:00 +0000
Heska extends product line with new Element COAG™ Veterinary Analyzer
"Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, announced today the release of the new Element COAG™ Veterinary Analyzer. The compact bench top analyzer delivers coagulation and blood typing parameters to complement Heska's Element leading chemistry, hematology, immunodiagnostics blood gas and electrolyte analyzers. Within minutes and with only 100uL of sample, Element COAG delivers accurate PT/aPTT (coagulation), Canine Fibrinogen, Equine Fibrinogen, Canine DEA 1.1 Blood Typing and Feline A/B Blood Typing.
Mon, 30 Oct 2017
15:57:03 +0000
ETFs with exposure to Heska Corp. : October 30, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Heska Corp. Here are 5 ETFs with the largest exposure to HSKA-US. Comparing the performance and risk of Heska Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more <b>(Read more...)</b>
Thu, 12 Oct 2017
12:00:00 +0000
Heska Schedules Third Quarter 2017 Financial Results Conference Call for November 2, 2017
LOVELAND, Colo. , Oct. 12, 2017 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, ...
Mon, 09 Oct 2017
12:41:48 +0000
Heska Corp. breached its 50 day moving average in a Bearish Manner : HSKA-US : October 9, 2017
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Heska Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more <b>(Read more...)</b>
Fri, 06 Oct 2017
13:04:37 +0000
Heska Corp. :HSKA-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017
Categories: Yahoo FinanceGet free summary analysis Heska Corp. reports financial results for the quarter ended June 30, 2017. Highlights Summary numbers: Revenues of USD 34.34 million, Net Earnings of USD 3.33 million. Gross margins widened from 42.32% to 43.48% compared to the same period last year, operating (EBITDA) margins now 16.48% from 15.59%. Change in operating cash ... Read more <b>(Read more...)</b>
Mon, 18 Sep 2017
14:01:02 +0000
TESARO Ovarian Cancer Drug Zejula Gets Positive CHMP Opinion
TESARO's (TSRO) marketing application for approval of its PARP-inhbitor Zejula as monotherapy for the maintenance treatment of ovarian cancer gets positive CHMP opinion.
Fri, 15 Sep 2017
15:22:03 +0000
The Zacks Analyst Blog Highlights: KEMET, Heska, Spirit AeroSystems, American Woodmark and Kraton
The Zacks Analyst Blog Highlights: KEMET, Heska, Spirit AeroSystems, American Woodmark and Kraton
Thu, 14 Sep 2017
21:39:09 +0000
4 Biotech Stocks That Show Promise on Sustainable Growth
Biotech sector is performing well in 2017 due to an increase in FDA approvals, new product sales ramp up, R&D success and innovation, strong clinical study results and continued strong performance of legacy products.
Thu, 14 Sep 2017
13:33:01 +0000
Obama-Trump Bull Run is the Second Best Ever: Top 5 Gainers
The S&P 500 surged 268% since bottoming in March 2009, while the index registered a staggering $2.04 trillion in market value since Trump's election last November
Mon, 28 Aug 2017
15:01:03 +0000
Zacks.com featured highlights Sanderson Farm, Heska Corp, Vanda Pharmaceuticals Lantheus and NVR
Zacks.com featured highlights Sanderson Farm, Heska Corp, Vanda Pharmaceuticals Lantheus and NVR
Fri, 25 Aug 2017
14:43:02 +0000
5 Efficient Stocks to Buy for a Healthy Portfolio
Companies with a favorable efficiency level is expected to provide impressive returns as it is believed to be positively correlated with its price performance



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "There is power in numbers. It's obvious that most brokers don't have a clue of what they recommend to clients. Rarely do they own what they are talking about. Here at VF it's real. Real people with real positions giving their takes on the good w/ the bad. "Knowledge always beats strength" is a great quote. Here, at VF, I hope to see the sharing of knowledge become our strength." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2017, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards